{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T10:23:14Z","timestamp":1789899794588,"version":"4.0.1"},"reference-count":83,"publisher":"American Society for Microbiology","issue":"9","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/100000060","name":"HHS | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["HHSN272201400006C"],"award-info":[{"award-number":["HHSN272201400006C"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2016,9]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            Antiviral drugs are important in preventing and controlling influenza, particularly when vaccines are ineffective or unavailable. A single class of antiviral drugs, the neuraminidase inhibitors (NAIs), is recommended for treating influenza. The limited therapeutic options and the potential risk of antiviral resistance are driving the search for additional small-molecule inhibitors that act on influenza virus proteins. The acid polymerase (PA) of influenza viruses is a promising target for new antivirals because of its essential role in initiating virus transcription. Here, we characterized a novel compound, RO-7, identified as a putative PA endonuclease inhibitor. RO-7 was effective when added before the cessation of genome replication, reduced polymerase activity in cell-free systems, and decreased relative amounts of viral mRNA and genomic RNA during influenza virus infection. RO-7 specifically inhibited the ability of the PA endonuclease domain to cleave a nucleic acid substrate. RO-7 also inhibited influenza A viruses (seasonal and 2009 pandemic H1N1 and seasonal H3N2) and B viruses (Yamagata and Victoria lineages), zoonotic viruses (H5N1, H7N9, and H9N2), and NAI-resistant variants in plaque reduction, yield reduction, and cell viability assays in Madin-Darby canine kidney (MDCK) cells with nanomolar to submicromolar 50% effective concentrations (EC\n            <jats:sub>50<\/jats:sub>\n            s), low toxicity, and favorable selective indices. RO-7 also inhibited influenza virus replication in primary normal human bronchial epithelial cells. Overall, RO-7 exhibits broad-spectrum activity against influenza A and B viruses in multiple\n            <jats:italic>in vitro<\/jats:italic>\n            assays, supporting its further characterization and development as a potential antiviral agent for treating influenza.\n          <\/jats:p>","DOI":"10.1128\/aac.00888-16","type":"journal-article","created":{"date-parts":[[2016,7,6]],"date-time":"2016-07-06T02:58:59Z","timestamp":1467773939000},"page":"5504-5514","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":50,"title":["A Novel Endonuclease Inhibitor Exhibits Broad-Spectrum Anti-Influenza Virus Activity\n            <i>In Vitro<\/i>"],"prefix":"10.1128","volume":"60","author":[{"given":"Jeremy C.","family":"Jones","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bindumadhav M.","family":"Marathe","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Lerner","sequence":"additional","affiliation":[{"name":"Roche Innovation Center, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Kreis","sequence":"additional","affiliation":[{"name":"Roche Innovation Center, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo","family":"Gasser","sequence":"additional","affiliation":[{"name":"Roche Innovation Center, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe Noriel Q.","family":"Pascua","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Najera","sequence":"additional","affiliation":[{"name":"Roche Innovation Center, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena A.","family":"Govorkova","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_3_2_2","volume-title":"Influenza","author":"World Health Organization","year":"2008","unstructured":"World Health Organization. 2008. Influenza. World Health Organization, Geneva, Switzerland. http:\/\/www.who.int\/immunization\/topics\/influenza\/en\/. Accessed 7 December 2015."},{"key":"e_1_3_3_3_2","volume-title":"Key facts about seasonal flu vaccine","author":"Centers for Disease Control and Prevention","year":"2015","unstructured":"Centers for Disease Control and Prevention. 2015. Key facts about seasonal flu vaccine. CDC, Atlanta, GA. http:\/\/www.cdc.gov\/flu\/protect\/keyfacts.htm#benefits. Accessed 7 December 2015."},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.2013.824709"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2015.05.023"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/irv.12176"},{"key":"e_1_3_3_7_2","first-page":"1","article-title":"Antiviral agents for the treatment and chemoprophylaxis of influenza \u2014 recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"60","author":"Fiore AE","year":"2011","unstructured":"Fiore AE, Fry A, Shay D, Gubareva L, Bresee JS, Uyeki TM, Centers for Disease Control and Prevention (CDC). 2011. Antiviral agents for the treatment and chemoprophylaxis of influenza \u2014 recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 60:1\u201324.","journal-title":"MMWR Recomm Rep"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0b013e3283199797"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/nyas.12462"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-405880-4.00006-8"},{"key":"e_1_3_3_11_2","volume-title":"Antiviral drug resistance among influenza viruses","author":"Centers for Disease Control and Prevention","year":"2015","unstructured":"Centers for Disease Control and Prevention. 2015. Antiviral drug resistance among influenza viruses. CDC, Atlanta, GA. http:\/\/www.cdc.gov\/flu\/professionals\/antivirals\/antiviral-drug-resistance.htm. Accessed January 2016."},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid2101\/141006"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-015-0361-6"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.3390\/molecules200712623"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2015.09.011"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/jphp.12294"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2015.03.017"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00152711"},{"key":"e_1_3_3_19_2","volume-title":"Antiviral drugs","author":"Centers for Disease Control and Prevention","year":"2015","unstructured":"Centers for Disease Control and Prevention. 2015. Antiviral drugs. CDC, Atlanta, GA. http:\/\/www.cdc.gov\/flu\/professionals\/antivirals\/index.htm. Accessed 8 December 2015."},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000144680.39895.ce"},{"key":"e_1_3_3_21_2","volume-title":"Phase 3 efficacy and safety study of favipiravir for treatment of uncomplicated influenza in adults\u2014T705US316","author":"National Institutes of Health","year":"2016","unstructured":"National Institutes of Health. 2016. Phase 3 efficacy and safety study of favipiravir for treatment of uncomplicated influenza in adults\u2014T705US316. National Institutes of Health, Bethesda, MD. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02026349?term=influenza+T705&rank=1. Accessed January 2016."},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2013.09.015"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00724-07"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1119817109"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2015.11.005"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.2174\/09298673113209990208"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-014-1615-2"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.2174\/1568026614666140929153812"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature07745"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.40.5.1304"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00832-13"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1021\/jo015665d"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.40.5.1189"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0019825"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1371\/currents.RRN1052"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1021\/mp400482a"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm020334u"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2013.08.053"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm500958x"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1021\/ml4001112"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0066337"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1021\/cb200439z"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002830"},{"key":"e_1_3_3_44_2","unstructured":"Takahashi C Mikamiyama H Akiyama T Tomita K Taoda Y Kawai M Anan K Miyagawa M Suzuki N. August 2013. Substituted polycyclic carbamoyl pyridone derivative prodrug. US patent 20 130 197 219 A1."},{"key":"e_1_3_3_45_2","first-page":"493","article-title":"A simple method for estimating fifty percent endpoints","volume":"27","author":"Reed LJ","year":"1938","unstructured":"Reed LJ, Muench LH. 1938. A simple method for estimating fifty percent endpoints. Am J Hyg 27:493\u2013497.","journal-title":"Am J Hyg"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1101143108"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01373-09"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jviromet.2010.12.014"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/27.5.1345"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2008.73"},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.1124\/mol.114.095588"},{"key":"e_1_3_3_52_2","unstructured":"ISIRV. 2014. Panel of influenza A and B viruses is for the assessment of neuraminidase inhibitor susceptibility. https:\/\/isirv.org\/site\/images\/AVG_panel_leaflet_Nov14.pdf. Accessed February 2016."},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5794"},{"key":"e_1_3_3_54_2","first-page":"1660","volume-title":"Fields virology","author":"Palese P","year":"2007","unstructured":"Palese P, Shaw ML. 2007. Orthomyxoviridae: the viruses and their replication, p 1660\u20131669. In Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (ed), Fields virology, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.","edition":"5"},{"key":"e_1_3_3_55_2","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1111\/irv.12077","article-title":"Brief literature review for the WHO global influenza research agenda\u2014highly pathogenic avian influenza H5N1 risk in humans","volume":"7","author":"Van Kerkhove MD","year":"2013","unstructured":"Van Kerkhove MD. 2013. Brief literature review for the WHO global influenza research agenda\u2014highly pathogenic avian influenza H5N1 risk in humans. Influenza Other Respir Viruses 7(Suppl 2):S26\u2013S33.","journal-title":"Influenza Other Respir Viruses"},{"key":"e_1_3_3_56_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.74.14.6592-6599.2000"},{"key":"e_1_3_3_57_2","doi-asserted-by":"publisher","DOI":"10.1038\/emi.2013.48"},{"key":"e_1_3_3_58_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid1909.130724"},{"key":"e_1_3_3_59_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0021183"},{"key":"e_1_3_3_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-3542(00)00125-X"},{"key":"e_1_3_3_61_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.41.2.742-750.2003"},{"key":"e_1_3_3_62_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2009.03.002"},{"key":"e_1_3_3_63_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.17.5.865"},{"key":"e_1_3_3_64_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01739-09"},{"key":"e_1_3_3_65_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.04623-14"},{"key":"e_1_3_3_66_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00125-11"},{"key":"e_1_3_3_67_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2007.12.010"},{"key":"e_1_3_3_68_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67338-2"},{"key":"e_1_3_3_69_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002431"},{"key":"e_1_3_3_70_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1187816"},{"key":"e_1_3_3_71_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms6029"},{"key":"e_1_3_3_72_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1001079"},{"key":"e_1_3_3_73_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiq067"},{"key":"e_1_3_3_74_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01424-10"},{"key":"e_1_3_3_75_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00995-10"},{"key":"e_1_3_3_76_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00600-06"},{"key":"e_1_3_3_77_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02346-12"},{"key":"e_1_3_3_78_2","doi-asserted-by":"publisher","DOI":"10.1254\/jphs.14156SC"},{"key":"e_1_3_3_79_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.03483-14"},{"key":"e_1_3_3_80_2","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-8-44"},{"key":"e_1_3_3_81_2","doi-asserted-by":"publisher","DOI":"10.1021\/ml4003474"},{"key":"e_1_3_3_82_2","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-11-167"},{"key":"e_1_3_3_83_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1519772113"},{"key":"e_1_3_3_84_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1402283"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00888-16","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00888-16","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T20:33:28Z","timestamp":1645475608000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.00888-16"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":83,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["10.1128\/AAC.00888-16"],"URL":"https:\/\/doi.org\/10.1128\/aac.00888-16","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"2016-04-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-06-27","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-08-22","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}